RK

Rajendra Kumar Verma

Active Director Director DIN 00598903
DIN 00598903 First appointment Mar 2002 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 6 historical roles
Total affiliations 9 Since Mar 2002
Shareholding value •••• Premium profile

About Rajendra Kumar Verma

Data last updated:

Rajendra Kumar Verma is a Director at Astam Diagnostics Private Limited (since 2017), Director at Astam Lifesciences Private Limited (since 2022) and Designated Partner at Agram Pharmaceuticals Llp (since 2015). The companies operate in Healthcare and Pharma. The largest current company by reported revenue is Astam Diagnostics Private Limited at ₹7.12 Cr (FY 2025). Earlier, Rajendra Kumar Verma was a Director at Vl Infratech Services Private Limited (2011–2022) and Director at Avizen Biopharma Private Limited (2016–2022) and 4 more.

DIN 00598903
Primary Designation Director
Industry Healthcare
First Appointment 05 Mar 2002
Oldest Company Age 16 yrs
Largest company Astam Diagnostics Private Limited · ₹7.12 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Astam Diagnostics Private Limited U74999DL2017PTC311351
Director02 Feb 20172017₹7.12 Cr (FY 2025)Active
Astam Lifesciences Private Limited U33119DL2022PTC403368
Director20 Aug 20222022Active
Designated Partner11 Jun 20152015Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Mar 20112011₹20,443 (FY 2025)Active
Avizen Biopharma Private Limited U24304AS2016PTC017532
Director09 Aug 20162016₹20.61 Cr (FY 2025)Active
Astam Healthcare Private Limited U24231HP2002PTC007833
Director05 Mar 20022002₹40.87 Cr (FY 2024)Active
Agam Enclave Private Limited U45201AS2009PTC009492
Director21 Dec 20092009Strike Off
Agram Optoelectronic Private Limited U74900DL2015PTC277027
Director21 Feb 20152015Strike Off
Aarvis Novo Private Limited U74999MH2018PTC305285
Director20 Feb 20182018Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Rajendra Kumar Verma

Directorship timeline

Open interactive timeline →
Astam Lifesciences Private Limited
Agam Enclave Private Limited
Agram Optoelectronic Private Limited
Astam Diagnostics Private Limited
Premium access

Shareholding and investment profile for Rajendra Kumar Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendra Kumar Verma

Rajendra Kumar Verma currently holds 3 directorships: Astam Diagnostics Private Limited (Director, since 02 Feb 2017, revenue ₹7.12 Cr (FY 2025)); Astam Lifesciences Private Limited (Director, since 20 Aug 2022); Agram Pharmaceuticals Llp (Designated Partner, since 11 Jun 2015).

Rajendra Kumar Verma was first appointed on 05 Mar 2002 as Director at Astam Healthcare Private Limited. The most recent appointment on record is 20 Aug 2022 at Astam Lifesciences Private Limited.

Rajendra Kumar Verma held 6 earlier board appointments: Vl Infratech Services Private Limited (Director, 29 Mar 2011 to 06 Jul 2022); Avizen Biopharma Private Limited (Director, 09 Aug 2016 to 06 Jul 2022); Astam Healthcare Private Limited (Director, 05 Mar 2002 to 25 Feb 2019); Agam Enclave Private Limited (Director, from 21 Dec 2009); Agram Optoelectronic Private Limited (Director, from 21 Feb 2015); and 1 more.

The current boards of Rajendra Kumar Verma's companies include Chandra Kala Verma (Astam Diagnostics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available